Tempus AI, Inc. Class A ( (TEM) ) is experiencing volatility. Read on for a possible explanation for the stock’s unusual movement.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Tempus AI, Inc. Class A shares climbed after the company posted preliminary fourth-quarter and full-year 2025 results that topped expectations, powered by robust growth in oncology and hereditary testing, expanding data and software applications, and a record $1.1 billion contract pipeline with strong recurring revenues. Investors also reacted positively to Tempus reaching positive EBITDA in 2025 and outlining a stronger 2026 outlook, with management modeling continued double-digit growth in both testing and data revenues, backed by potential catalysts such as pediatric rare-disease testing, new regulatory approvals, improved reimbursement, and an expanding roster of partnerships. At the same time, a recent pickup in insider selling has injected some caution into the story, leaving the near-term picture more mixed even as the longer-term growth path appears more optimistic.
More about Tempus AI, Inc. Class A
YTD Price Performance: 10.62%
Average Trading Volume: 5,131,578
Technical Sentiment Signal: Sell
Current Market Cap: $11.62B
For further insights into TEM stock on TipRanks’ Stock Analysis page.
See more of today’s top stock gainers and losers.